Gene Therapy: A Big Week for Many Names – Barron’s
|
Gene Therapy: A Big Week for Many Names
Barron’s We believe this news supports our established thesis that M&A opportunities exist in the GT space, thus providing ample reason to be solidly overweight in gene therapy companies. As we reported in this very blog last week, Alnylam Pharmaceuticals (ALNY … |
